John Reed

John C.
Reed is the founder of Idun Pharmaceuticals, Inc., founded in 1993, and Apoptos, Inc., founded in 2007.
Dr. Reed is currently Chief Executive Officer at Synthorx, Inc. since 2020 and Executive Vice President-Innovative Medicine at Johnson & Johnson.
Former positions include President, Chief Executive Officer & Professor at Sanford Burnham Prebys Medical Discovery Institute from 1992 to 2013; Director at Repros Therapeutics, Inc. from 2008 to 2009; Independent Director at Ionis Pharmaceuticals, Inc. from 2011 to 2013; Director at Pharmion Corp.
from 2005 to 2008; Assistant Director at the University of Pennsylvania from 1988 to 1989; Director at Stratagene Corp.; Director at CONNECT; Independent Director at Clovis Oncology, Inc. from 2011 to 2013; Director at Biocom, Inc.; Head-Roche Pharma Research & Early Development at Roche Holding AG from 2013 to 2018; EVP & Global Head-Research & Development at Sanofi from 2018 to 2023; Associate Member at the University of California San Diego from 2012 to 2013; Associate Member at Whitaker Institute of Biomedical Engineering from 2002 to 2013; and President at Principia Biopharma, Inc. Education includes an undergraduate degree from the University of Virginia in 1980 and a doctorate from the University of Pennsylvania Medical Center.